Cargando…
Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial
Objective To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates. Design Randomised, placebo controlled, two by two factorial trial. Setting Bissau, Guinea-Bissau. Participants 1717 low birthweight neonates born at the national hospital. Inter...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835853/ https://www.ncbi.nlm.nih.gov/pubmed/20215360 http://dx.doi.org/10.1136/bmj.c1101 |
_version_ | 1782178667538939904 |
---|---|
author | Benn, Christine Stabell Fisker, Ane Bærent Napirna, Bitiguida Mutna Roth, Adam Diness, Birgitte Rode Lausch, Karen Rokkedal Ravn, Henrik Yazdanbakhsh, Maria Rodrigues, Amabelia Whittle, Hilton Aaby, Peter |
author_facet | Benn, Christine Stabell Fisker, Ane Bærent Napirna, Bitiguida Mutna Roth, Adam Diness, Birgitte Rode Lausch, Karen Rokkedal Ravn, Henrik Yazdanbakhsh, Maria Rodrigues, Amabelia Whittle, Hilton Aaby, Peter |
author_sort | Benn, Christine Stabell |
collection | PubMed |
description | Objective To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates. Design Randomised, placebo controlled, two by two factorial trial. Setting Bissau, Guinea-Bissau. Participants 1717 low birthweight neonates born at the national hospital. Intervention Neonates who weighed less than 2.5 kg were randomly assigned to 25 000 IU vitamin A or placebo, as well as to early BCG vaccine or the usual late BCG vaccine, and were followed until age 12 months. Main outcome measure Mortality, calculated as mortality rate ratios (MRRs), after follow-up to 12 months of age for infants who received vitamin A supplementation compared with those who received placebo. Results No interaction was observed between vitamin A supplementation and BCG vaccine allocation (P=0.73). Vitamin A supplementation at birth was not significantly associated with mortality: the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to “early BCG” versus “no early BCG” was 1.08 (95% CI 0.79 to 1.47). Stratification by sex revealed a significant interaction between vitamin A supplementation and sex (P=0.046), the MRR of vitamin A supplementation being 0.74 (95% CI 0.45 to 1.22) in boys and 1.42 (95% CI 0.94 to 2.15) in girls. When these data were combined with data from a complementary trial among normal birthweight neonates in Guinea-Bissau, the combined estimate of the effect of neonatal vitamin A supplementation on mortality was 1.08 (95% CI 0.87 to 1.33); 0.80 (95% CI 0.58 to 1.10) in boys and 1.41 (95% CI 1.04 to 1.90) in girls (P=0.01 for interaction between neonatal vitamin A and sex). Conclusions The combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau. Worryingly, the trials show that vitamin A supplementation at birth can be harmful in girls. Previous studies and future trials should investigate the possibility that vitamin A supplementation has sex differential effects. Trial registration ClinicalTrials.gov NCT00168610. |
format | Text |
id | pubmed-2835853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | BMJ Publishing Group Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-28358532010-03-11 Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial Benn, Christine Stabell Fisker, Ane Bærent Napirna, Bitiguida Mutna Roth, Adam Diness, Birgitte Rode Lausch, Karen Rokkedal Ravn, Henrik Yazdanbakhsh, Maria Rodrigues, Amabelia Whittle, Hilton Aaby, Peter BMJ Research Objective To investigate the effect of vitamin A supplementation and BCG vaccination at birth in low birthweight neonates. Design Randomised, placebo controlled, two by two factorial trial. Setting Bissau, Guinea-Bissau. Participants 1717 low birthweight neonates born at the national hospital. Intervention Neonates who weighed less than 2.5 kg were randomly assigned to 25 000 IU vitamin A or placebo, as well as to early BCG vaccine or the usual late BCG vaccine, and were followed until age 12 months. Main outcome measure Mortality, calculated as mortality rate ratios (MRRs), after follow-up to 12 months of age for infants who received vitamin A supplementation compared with those who received placebo. Results No interaction was observed between vitamin A supplementation and BCG vaccine allocation (P=0.73). Vitamin A supplementation at birth was not significantly associated with mortality: the MRR of vitamin A supplementation compared with placebo, controlled for randomisation to “early BCG” versus “no early BCG” was 1.08 (95% CI 0.79 to 1.47). Stratification by sex revealed a significant interaction between vitamin A supplementation and sex (P=0.046), the MRR of vitamin A supplementation being 0.74 (95% CI 0.45 to 1.22) in boys and 1.42 (95% CI 0.94 to 2.15) in girls. When these data were combined with data from a complementary trial among normal birthweight neonates in Guinea-Bissau, the combined estimate of the effect of neonatal vitamin A supplementation on mortality was 1.08 (95% CI 0.87 to 1.33); 0.80 (95% CI 0.58 to 1.10) in boys and 1.41 (95% CI 1.04 to 1.90) in girls (P=0.01 for interaction between neonatal vitamin A and sex). Conclusions The combined results of this trial and the complementary trial among normal birthweight neonates have now shown that, overall, it would not be beneficial to implement a neonatal vitamin A supplementation policy in Guinea-Bissau. Worryingly, the trials show that vitamin A supplementation at birth can be harmful in girls. Previous studies and future trials should investigate the possibility that vitamin A supplementation has sex differential effects. Trial registration ClinicalTrials.gov NCT00168610. BMJ Publishing Group Ltd. 2010-03-09 /pmc/articles/PMC2835853/ /pubmed/20215360 http://dx.doi.org/10.1136/bmj.c1101 Text en © Benn et al 2010 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode. |
spellingShingle | Research Benn, Christine Stabell Fisker, Ane Bærent Napirna, Bitiguida Mutna Roth, Adam Diness, Birgitte Rode Lausch, Karen Rokkedal Ravn, Henrik Yazdanbakhsh, Maria Rodrigues, Amabelia Whittle, Hilton Aaby, Peter Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
title | Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
title_full | Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
title_fullStr | Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
title_full_unstemmed | Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
title_short | Vitamin A supplementation and BCG vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
title_sort | vitamin a supplementation and bcg vaccination at birth in low birthweight neonates: two by two factorial randomised controlled trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835853/ https://www.ncbi.nlm.nih.gov/pubmed/20215360 http://dx.doi.org/10.1136/bmj.c1101 |
work_keys_str_mv | AT bennchristinestabell vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT fiskeranebærent vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT napirnabitiguidamutna vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT rothadam vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT dinessbirgitterode vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT lauschkarenrokkedal vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT ravnhenrik vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT yazdanbakhshmaria vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT rodriguesamabelia vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT whittlehilton vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial AT aabypeter vitaminasupplementationandbcgvaccinationatbirthinlowbirthweightneonatestwobytwofactorialrandomisedcontrolledtrial |